https://cladribineinhibitor.co....m/spotty-hypoxic-con
As antibody concentrations are not comparable between practices, appropriate cut-off values should be founded for each method. For a third-generation TRAb assay (Phadia, Thermofisher), the manufacturer determined the cut-off price in a research population consisting of Graves' illness (both newly diagnosed and patients under treatment) and non-Graves' disease clients. The aim of this study would be to validate whether this cut-off value holds true within our po
Like
Comment
Share
